Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Exp Cell Res

Retrieve available abstracts of 11 articles:
HTML format

Single Articles

    March 2024
  1. ENLUND S, Sinha I, Neofytou C, Amor AR, et al
    The CNS microenvironment promotes leukemia cell survival by disrupting tumor suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic leukemia.
    Exp Cell Res. 2024 Mar 30:114015. doi: 10.1016/j.yexcr.2024.114015.
    PubMed     Abstract available

    December 2023
  2. ZURLO M, Gasparello J, Verona M, Papi C, et al
    The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells.
    Exp Cell Res. 2023;433:113853.
    PubMed     Abstract available

    September 2023
  3. ZHANG L, Luo L, Zheng Q, Wang W, et al
    Emodin derivative E35 and its combination with autophagy inhibitor against acute myeloid leukemia cells in vitro and in vivo.
    Exp Cell Res. 2023 Sep 22:113780. doi: 10.1016/j.yexcr.2023.113780.
    PubMed     Abstract available

    May 2023
  4. BLACHIER J, Cleret A, Guerin N, Gil C, et al
    L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Exp Cell Res. 2023;426:113568.
    PubMed     Abstract available

    October 2022
  5. YI ZN, Chen XK, Ma AC
    Modeling leukemia with zebrafish (Danio rerio): Towards precision medicine.
    Exp Cell Res. 2022 Oct 25:113401. doi: 10.1016/j.yexcr.2022.113401.
    PubMed     Abstract available

  6. ZHENG D, Qiwen Zeng, He D, He Y, et al
    SIRT5 alleviates hepatic ischemia and reperfusion injury by diminishing oxidative stress and inflammation via elevating SOD1 and IDH2 expression.
    Exp Cell Res. 2022;419:113319.
    PubMed     Abstract available

    September 2022
  7. JIA J, Liu B, Wang D, Wang X, et al
    CD93 promotes acute myeloid leukemia development and is a potential therapeutic target.
    Exp Cell Res. 2022;420:113361.
    PubMed     Abstract available

    August 2022
  8. CHEN CW, Huang NK, Lee YL, Fan CK, et al
    Activin A downregulates the CD69-MT2A axis via p38MAPK to induce erythroid differentiation that sensitizes BCR-ABL-positive cells to imatinib.
    Exp Cell Res. 2022;417:113219.
    PubMed     Abstract available

    May 2022
  9. LIU H, Hussain Z, Xie Q, Yan X, et al
    Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax.
    Exp Cell Res. 2022 May 11:113192. doi: 10.1016/j.yexcr.2022.113192.
    PubMed     Abstract available

    March 2022
  10. ZHANG Y, Guo H, Zhang Z, Lu W, et al
    IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia.
    Exp Cell Res. 2022;415:113112.
    PubMed     Abstract available

    June 2021
  11. LIU Z, Zheng W, Liu Y, Zhou B, et al
    Targeting HSPA8 inhibits proliferation via downregulating BCR-ABL and enhances chemosensitivity in imatinib-resistant chronic myeloid leukemia cells.
    Exp Cell Res. 2021 Jun 19:112708. doi: 10.1016/j.yexcr.2021.112708.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.